We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$105M
AUM Growth
+$31M
Cap. Flow
+$23.6M
Cap. Flow %
22.35%
Top 10 Hldgs %
37.42%
Holding
105
New
22
Increased
35
Reduced
19
Closed
22

Top Buys

Rank Stock Value
1
SNNA
Sienna Biopharmaceuticals, Inc.
SNNA
+$6.61M
2
AGN.PRA
Allergan plc
AGN.PRA
+$1.98M
3
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$1.72M
4
CNC icon
Centene
CNC
+$1.44M
5
JD icon
JD.com
JD
+$1.26M

Top Sells

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$4.01M
2
UHS icon
Universal Health Services
UHS
+$1.84M
3
PCRX icon
Pacira BioSciences
PCRX
+$1.72M
4
MCK icon
McKesson
MCK
+$1.63M
5
BABA icon
Alibaba
BABA
+$1.15M

Sector Composition

Rank Sector Weight
1 Healthcare 34.37%
2 Technology 14.09%
3 Communication Services 5.97%
4 Consumer Discretionary 5.14%
5 Financials 3.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MOH icon
51
CALL
Molina Healthcare
MOH
$9.99B
$667K 0.63%
+9,700
New +$631K
EVH icon
52
Evolent Health
EVH
$350M
$593K 0.56%
33,325
+25,358
+318% +$522K
ICLR icon
53
Icon
ICLR
$12.1B
$566K 0.54%
4,972
+700
+16% +$74.4K
NVDA icon
54
NVIDIA
NVDA
$5.13T
$522K 0.5%
116,800
+26,040
+29% +$108K
TREE icon
55
LendingTree
TREE
$474M
$503K 0.48%
2,057
+473
+30% +$102K
SWKS icon
56
Skyworks Solutions
SWKS
$10.1B
$481K 0.46%
+4,721
New +$490K
BLK icon
57
Blackrock
BLK
$175B
$480K 0.46%
1,073
+57
+6% +$24.3K
XYZ
58
Block Inc
XYZ
$50.4B
$475K 0.45%
16,476
-1,962
-11% -$51.4K
V icon
59
Visa
V
$690B
$474K 0.45%
4,502
-7,912
-64% -$802K
ESPR
60
DELISTED
Esperion Therapeutics
ESPR
$457K 0.43%
9,119
+5,096
+127% +$246K
MMSI icon
61
Merit Medical Systems
MMSI
$5.12B
$452K 0.43%
10,680
+4,572
+75% +$184K
ELGX
62
DELISTED
Endologix Inc
ELGX
$441K 0.42%
9,882
-92
-0.9% -$4.19K
HRC
63
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$396K 0.38%
5,356
+2,483
+86% +$191K
KURA icon
64
Kura Oncology
KURA
$841M
$384K 0.36%
25,717
+2,921
+13% +$27.4K
INGN icon
65
Inogen
INGN
$187M
$348K 0.33%
+3,659
New +$353K
CLVS
66
DELISTED
Clovis Oncology, Inc.
CLVS
$334K 0.32%
4,053
-2,551
-39% -$202K
XENT
67
DELISTED
Intersect ENT, Inc
XENT
$309K 0.29%
9,913
+2,902
+41% +$85.9K
VMC icon
68
Vulcan Materials
VMC
$36.9B
$298K 0.28%
2,488
– –
HAPN
69
Happen Inc
HAPN
$2.41B
$233K 0.22%
+7,655
New +$220K
JNCE
70
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$222K 0.21%
14,265
+7,170
+101% +$101K
CSII
71
DELISTED
Cardiovascular Systems, Inc.
CSII
$186K 0.18%
6,602
+582
+10% +$17.7K
ARAY icon
72
Accuray
ARAY
$37.2M
$185K 0.18%
46,229
-5,699
-11% -$24.5K
CUTR
73
DELISTED
Cutera, Inc.
CUTR
$180K 0.17%
+4,349
New +$143K
PRAH
74
DELISTED
PRA Health Sciences, Inc.
PRAH
$142K 0.13%
+1,865
New +$141K
MDXG icon
75
PUT
MiMedx Group
MDXG
$622M
$137K 0.13%
+11,500
New +$171K
1 2
3
4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Partner Investment Management held 105 positions worth $105M, up 42% from $74.4M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Partner Investment Management deployed $23.6M of net new capital in Q3 2017, opening 22 new positions and adding to 35 existing holdings. Its largest new stake was Sienna Biopharmaceuticals, Inc.: 300,940 shares worth $6.7M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 39% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Kite Pharma, Inc., an estimated $4.01M trimmed.

  • Partner Investment Management's largest Q3 2017 buy was Sienna Biopharmaceuticals, Inc.: 300,940 shares worth $6.7M.
  • Partner Investment Management added most to Portola Pharmaceuticals, Inc. in Q3 2017, an estimated $1.72M increase.
  • Partner Investment Management's biggest Q3 2017 reduction was Kite Pharma, Inc., cutting an estimated $4.01M.
  • Partner Investment Management fully exited Universal Health Services in Q3 2017, selling an estimated $1.84M.
  • Partner Investment Management's ten largest holdings make up 37% of its $105M portfolio in Q3 2017.
  • Partner Investment Management opened 22 new positions and closed 22 in Q3 2017.
  • Partner Investment Management's portfolio value rose 42% quarter-over-quarter to $105M.

Based on Partner Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.